NASDAQ · Analyst Forecast

Cyngn Inc. (CYN) Analyst Forecast

$0.37 NASDAQ: CYN Market Cap $5.74M

Revenue and earnings estimates published by analysts covering Cyngn Inc. (CYN), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Cyngn Inc., analysts forecast revenue rising from $1.50T in 2023 to $50.69T in 2028; the average estimate for 2028 earnings per share is $1201.50; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD millions)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

Year	Low	Average	High	Analysts
2023	$1.50T	$1.50T	$1.50T	1
2024	$120.0B	$120.0B	$120.0B	1
2025	$500.0B	$500.0B	$500.0B	1
2026	$1.15T	$1.15T	$1.15T	1
2027	$8.00T	$8.00T	$8.00T	1
2028	$50.69T	$50.69T	$50.69T	1

Earnings per share forecast

Year	Low	Average	High	Analysts
2023	$-8625.00	$-8625.00	$-8625.00	1
2024	$-2427.00	$-2427.00	$-2427.00	1
2025	$-6.97	$-6.97	$-6.97	1
2026	$-2.02	$-2.02	$-2.02	1
2027	$-1.46	$-1.46	$-1.46	1
2028	$1201.50	$1201.50	$1201.50	1

Cyngn Inc. (CYN) forecast — frequently asked questions

What are analysts forecasting for Cyngn Inc.'s earnings?

The average analyst estimate for Cyngn Inc. (CYN) earnings per share in 2028 is 1201.50, with individual estimates between 1201.50 and 1201.50.

How much revenue is Cyngn Inc. expected to make?

Analysts forecast Cyngn Inc. (CYN) revenue of $50.69T in 2028, based on 1 published estimates.

How many analysts cover CYN?

1 analyst contribute estimates for Cyngn Inc. (CYN). Thin coverage makes an average less reliable.

Related stock screens

High ROE Technology Stocks Low P/E Technology Stocks High Net Margin Technology Stocks Dividend Technology Stocks Low Debt Technology Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks Nasdaq High ROE Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.